Caffard, Thomas
Chiapparelli, Erika
Arzani, Artine
Tani, Soji
Camino-Willhuber, Gaston
Finos, Kyle
Burkhard, Marco D.
Zippelius, Timo
Breighner, Ryan E.
Carrino, John A.
Dalton, David
Hughes, Alexander P. https://orcid.org/0000-0001-7293-9672
Article History
Received: 12 June 2024
Accepted: 26 October 2024
First Online: 21 November 2024
Declarations
:
: The authors have no relevant financial or non-financial interests to disclose. Dr. Carrino reports consulting for Pfizer, Inc; Eli-Lilly; Globus Medical, Inc.; Regeneron; AstraZeneca; scientific advisory board/other office position with Carestream; Image Analysis Group; Image Biopsy Lab. Dr. Hughes reports research support from Kuros Biosciences AG and Expanding Innovations, Inc.; private investments in Tissue Connect Systems, Inc.; and fellowship support from NuVasive, Inc. outside the submitted work.
: This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Institutional Review Board (IRB) of Hospital for Special Surgery approved this study (#2023–0413).
: Informed consent was waived due to the retrospective nature of the study.